You are here

  • Home
  • Archive
  • Volume 74, Issue 2
  • Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Alerts

Article menu

This article has a correction. Please see:

Download PDFPDF

Download PDF + Supplemental DataPDF +
Supplementary
Material

Clinical and epidemiological research
Extended report
Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address